Distinct IL-1α-responsive enhancers promote acute and coordinated changes in chromatin topology in a hierarchical manner.
Binding Sites
Cells, Cultured
Chemokines
/ metabolism
Chromatin
/ chemistry
Enhancer Elements, Genetic
/ genetics
Gene Expression Regulation
/ drug effects
HeLa Cells
Humans
Inflammation Mediators
/ metabolism
Interleukin-1alpha
/ pharmacology
MAP Kinase Kinase Kinases
/ genetics
NF-kappa B
/ genetics
Signal Transduction
Tumor Necrosis Factor-alpha
/ pharmacology
IL-8
NF-κB
chromatin topology
interleukin-1
tumor necrosis factor-α
Journal
The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664
Informations de publication
Date de publication:
02 01 2020
02 01 2020
Historique:
received:
11
01
2019
revised:
27
09
2019
accepted:
01
10
2019
pubmed:
9
11
2019
medline:
14
7
2020
entrez:
9
11
2019
Statut:
ppublish
Résumé
How cytokine-driven changes in chromatin topology are converted into gene regulatory circuits during inflammation still remains unclear. Here, we show that interleukin (IL)-1α induces acute and widespread changes in chromatin accessibility via the TAK1 kinase and NF-κB at regions that are highly enriched for inflammatory disease-relevant SNPs. Two enhancers in the extended chemokine locus on human chromosome 4 regulate the IL-1α-inducible IL8 and CXCL1-3 genes. Both enhancers engage in dynamic spatial interactions with gene promoters in an IL-1α/TAK1-inducible manner. Microdeletions of p65-binding sites in either of the two enhancers impair NF-κB recruitment, suppress activation and biallelic transcription of the IL8/CXCL2 genes, and reshuffle higher-order chromatin interactions as judged by i4C interactome profiles. Notably, these findings support a dominant role of the IL8 "master" enhancer in the regulation of sustained IL-1α signaling, as well as for IL-8 and IL-6 secretion. CRISPR-guided transactivation of the IL8 locus or cross-TAD regulation by TNFα-responsive enhancers in a different model locus supports the existence of complex enhancer hierarchies in response to cytokine stimulation that prime and orchestrate proinflammatory chromatin responses downstream of NF-κB.
Identifiants
pubmed: 31701553
doi: 10.15252/embj.2019101533
pmc: PMC6939198
doi:
Substances chimiques
Chemokines
0
Chromatin
0
IL1A protein, human
0
Inflammation Mediators
0
Interleukin-1alpha
0
NF-kappa B
0
Tumor Necrosis Factor-alpha
0
MAP Kinase Kinase Kinases
EC 2.7.11.25
MAP kinase kinase kinase 7
EC 2.7.11.25
Banques de données
GEO
['GSE64224', 'GSE52470', 'GSE134436']
SRA
['PRJNA552438']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e101533Subventions
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 162103480
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 284237345
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 183582903
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 268555672
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 197785619
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 162103480
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 183582903
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 197785619
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 285697699
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 290613333
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 24676099
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 390649896
Pays : International
Organisme : Deutsche Krebshilfe
ID : 111447
Pays : International
Organisme : Max-Planck Society
Pays : International
Organisme : Excellence Cluster Cardio-Pulmonary System and Cardio-Pulmonary Institute (EXC 147: Kardiopulmonales System)
ID : 24676099
Pays : International
Organisme : Cardio-Pulmonary Institute (CPI)
ID : 390649896
Pays : International
Organisme : DZL/UGMLC Program
Pays : International
Organisme : Center for Molecular Medicine Cologne (ZMMK)
Pays : International
Informations de copyright
© 2019 The Authors. Published under the terms of the CC BY 4.0 license.
Références
Mol Cell. 2017 Dec 21;68(6):1067-1082.e12
pubmed: 29272704
J Biol Chem. 2005 Mar 11;280(10):9706-18
pubmed: 15615716
J Vis Exp. 2018 Apr 2;(134):
pubmed: 29658938
Trends Biochem Sci. 2017 Aug;42(8):612-624
pubmed: 28566214
Methods Mol Biol. 2016;1418:335-51
pubmed: 27008022
Mol Cell. 2014 Jan 23;53(2):193-208
pubmed: 24389100
Nat Genet. 2019 Jan;51(1):138-150
pubmed: 30531872
J Biol Chem. 1994 Dec 16;269(50):31836-44
pubmed: 7527398
Mediators Inflamm. 2017;2017:7848591
pubmed: 28490839
Hum Mol Genet. 2017 Feb 15;26(4):742-752
pubmed: 28007912
Trends Cell Biol. 2018 Aug;28(8):608-630
pubmed: 29759817
Epigenomics. 2017 Sep;9(9):1219-1231
pubmed: 28799793
Nat Rev Drug Discov. 2009 Jun;8(6):480-99
pubmed: 19483709
Cell Rep. 2015 Feb 10;10(5):726-739
pubmed: 25660023
Nat Genet. 2008 Jul;40(7):897-903
pubmed: 18552846
J Exp Med. 1955 Jul 1;102(1):37-48
pubmed: 14392239
Nature. 2015 Jan 29;517(7536):583-8
pubmed: 25494202
Nat Protoc. 2013 Mar;8(3):509-24
pubmed: 23411633
Annu Rev Immunol. 2014;32:489-511
pubmed: 24555473
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Mol Cell Biol. 2012 Jul;32(14):2738-47
pubmed: 22586273
Theranostics. 2017 Apr 7;7(6):1543-1588
pubmed: 28529637
Nat Commun. 2018 Jul 25;9(1):2905
pubmed: 30046115
Immunol Cell Biol. 2007 Jun;85(4):315-22
pubmed: 17438562
Genome Res. 2016 Nov;26(11):1478-1489
pubmed: 27633323
Cell. 2018 Apr 5;173(2):386-399.e12
pubmed: 29625054
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Rev Genet. 2013 Jun;14(6):390-403
pubmed: 23657480
Curr Opin Cell Biol. 2013 Dec;25(6):759-64
pubmed: 23906851
Mol Biol Cell. 2009 Apr;20(7):2070-82
pubmed: 19211845
Mol Cell. 2016 Apr 21;62(2):237-247
pubmed: 27067601
Cold Spring Harb Perspect Biol. 2014 Sep 11;6(11):a016261
pubmed: 25213094
PLoS Biol. 2010 Jul 13;8(7):e1000419
pubmed: 20644712
Cytokine. 1997 Jul;9(7):471-9
pubmed: 9237809
Nat Commun. 2018 Mar 5;9(1):943
pubmed: 29507293
Proc Soc Exp Biol Med. 1955 Jul;89(3):362-4
pubmed: 13254761
BMC Genomics. 2014 Apr 15;15:284
pubmed: 24735413
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Cell. 2008 Jul 11;134(1):85-96
pubmed: 18614013
Annu Rev Cell Dev Biol. 2017 Oct 6;33:265-289
pubmed: 28783961
Oncogene. 2018 Jun;37(23):3070-3087
pubmed: 29535421
Wiley Interdiscip Rev Syst Biol Med. 2018 Jan;10(1):
pubmed: 28544514
J Cell Biol. 2019 Jan 7;218(1):12-26
pubmed: 30442643
Annu Rev Immunol. 2010;28:321-42
pubmed: 20307211
Nat Immunol. 2011 Jul 19;12(8):695-708
pubmed: 21772278
Nature. 2012 Sep 6;489(7414):75-82
pubmed: 22955617
J Biol Chem. 2005 Feb 25;280(8):7010-21
pubmed: 15591054
Nat Commun. 2017 Nov 29;8(1):1849
pubmed: 29185442
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Science. 2018 Sep 28;361(6409):1341-1345
pubmed: 30262496
Genome Biol. 2014 Dec 03;15(12):536
pubmed: 25608606
Mol Cell. 2017 Sep 21;67(6):1037-1048.e6
pubmed: 28890333
Chem Rev. 2015 Mar 25;115(6):2274-95
pubmed: 25424540
Curr Opin Immunol. 2017 Feb;44:34-42
pubmed: 27951434
Cytokine Growth Factor Rev. 2016 Oct;31:61-71
pubmed: 27578214
Biochem J. 1991 Aug 1;277 ( Pt 3):635-42
pubmed: 1872799
Nat Commun. 2018 Apr 25;9(1):1661
pubmed: 29695774
J Cell Biol. 2019 Jan 7;218(1):27-38
pubmed: 30181316
Immunity. 2010 Mar 26;32(3):317-28
pubmed: 20206554
Cell. 2016 Nov 17;167(5):1170-1187
pubmed: 27863239
Sci Signal. 2010 Jan 19;3(105):cm2
pubmed: 20086236
Nat Rev Immunol. 2014 Jan;14(1):51-9
pubmed: 24336099
Mol Cell. 2013 Mar 7;49(5):773-82
pubmed: 23473598
Methods Mol Biol. 2013;946:27-38
pubmed: 23179824
Nucleic Acids Res. 2014 Apr;42(8):e68
pubmed: 24561615
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
J Vis Exp. 2013 Aug 15;(78):null
pubmed: 23978815
Trends Cell Biol. 2018 Jul;28(7):509-511
pubmed: 29778529
Nat Genet. 2018 Aug;50(8):1151-1160
pubmed: 29988121
Epigenomics. 2018 Apr 1;10(4):483-498
pubmed: 29583027
Biochem J. 2003 Aug 15;374(Pt 1):1-20
pubmed: 12773095
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Trends Pharmacol Sci. 2012 Oct;33(10):522-30
pubmed: 22795313
Nat Med. 2018 Sep;24(9):1469-1480
pubmed: 30038216
Mol Syst Biol. 2016 Dec 9;12(12):891
pubmed: 27940490
Cancer Res. 2017 Jun 1;77(11):2784-2788
pubmed: 28455420
EMBO J. 2012 Nov 28;31(23):4404-14
pubmed: 23103767
Nat Rev Immunol. 2017 Oct;17(10):595-607
pubmed: 28580958
J Cell Biol. 2011 Aug 22;194(4):581-96
pubmed: 21859862
Cell. 1994 Sep 23;78(6):1039-49
pubmed: 7923354